ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 63 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,261,000 | -31.5% | 2,740,000 | 0.0% | 0.01% | -38.5% |
| Q2 2020 | $16,440,000 | -20.3% | 2,740,000 | 0.0% | 0.01% | -40.9% |
| Q1 2020 | $20,632,000 | -45.2% | 2,740,000 | 0.0% | 0.02% | -38.9% |
| Q4 2019 | $37,675,000 | +242.8% | 2,740,000 | +196.2% | 0.04% | +200.0% |
| Q3 2019 | $10,989,000 | -15.1% | 925,000 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $12,941,000 | -21.8% | 925,000 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $16,539,000 | +13.7% | 925,000 | 0.0% | 0.02% | -5.3% |
| Q4 2018 | $14,550,000 | – | 925,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |